Hisashi Tsurumi

5.9k total citations
201 papers, 3.7k citations indexed

About

Hisashi Tsurumi is a scholar working on Pathology and Forensic Medicine, Oncology and Hematology. According to data from OpenAlex, Hisashi Tsurumi has authored 201 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Pathology and Forensic Medicine, 50 papers in Oncology and 45 papers in Hematology. Recurrent topics in Hisashi Tsurumi's work include Lymphoma Diagnosis and Treatment (55 papers), Acute Myeloid Leukemia Research (25 papers) and Retinoids in leukemia and cellular processes (24 papers). Hisashi Tsurumi is often cited by papers focused on Lymphoma Diagnosis and Treatment (55 papers), Acute Myeloid Leukemia Research (25 papers) and Retinoids in leukemia and cellular processes (24 papers). Hisashi Tsurumi collaborates with scholars based in Japan, United States and Germany. Hisashi Tsurumi's co-authors include Hisataka Moriwaki, Masahito Shimizu, Takeshi Hara, Yohei Shirakami, Takuji Tanaka, Senji Kasahara, Hiroyasu Sakai, Nobuhiro Kanemura, Naoe Goto and Tsuyoshi Takami and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Hisashi Tsurumi

190 papers receiving 3.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hisashi Tsurumi Japan 37 1.1k 943 909 592 563 201 3.7k
Dilip K. Deb United States 31 1.1k 1.1× 1.1k 1.2× 567 0.6× 371 0.6× 586 1.0× 41 3.3k
Patrick D. Walker United States 42 1.4k 1.3× 767 0.8× 498 0.5× 344 0.6× 514 0.9× 122 5.1k
Salvatore Mancuso Italy 40 1.6k 1.4× 431 0.5× 1.0k 1.1× 386 0.7× 612 1.1× 149 5.1k
Lynell W. Klassen United States 39 704 0.6× 910 1.0× 547 0.6× 864 1.5× 1.2k 2.1× 137 5.0k
Yasumasa Ikeda Japan 34 970 0.9× 336 0.4× 418 0.5× 441 0.7× 252 0.4× 151 3.5k
Karen W. Makar United States 32 1.4k 1.3× 601 0.6× 995 1.1× 286 0.5× 1.3k 2.2× 78 3.7k
James P. Luyendyk United States 41 1.2k 1.1× 297 0.3× 723 0.8× 1.7k 2.8× 735 1.3× 115 4.9k
Huihua Li United States 36 2.1k 1.9× 340 0.4× 683 0.8× 400 0.7× 392 0.7× 106 4.1k
Roger Feakins United Kingdom 34 821 0.8× 428 0.5× 955 1.1× 1.0k 1.8× 446 0.8× 85 3.7k
Josep M. Piqué Spain 39 622 0.6× 410 0.4× 824 0.9× 761 1.3× 612 1.1× 123 4.3k

Countries citing papers authored by Hisashi Tsurumi

Since Specialization
Citations

This map shows the geographic impact of Hisashi Tsurumi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hisashi Tsurumi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hisashi Tsurumi more than expected).

Fields of papers citing papers by Hisashi Tsurumi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hisashi Tsurumi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hisashi Tsurumi. The network helps show where Hisashi Tsurumi may publish in the future.

Co-authorship network of co-authors of Hisashi Tsurumi

This figure shows the co-authorship network connecting the top 25 collaborators of Hisashi Tsurumi. A scholar is included among the top collaborators of Hisashi Tsurumi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hisashi Tsurumi. Hisashi Tsurumi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nakamura, Nobuhiko, Nobuhiro Kanemura, Takuro Matsumoto, et al.. (2024). Effect of Vitamin D and Skeletal Muscle Mass on Prognosis of Patients with Diffuse Large B-Cell Lymphoma. Nutrients. 16(16). 2653–2653.
2.
Lee, Shin, Tetsuji Morishita, Eiju Negoro, et al.. (2023). The Relative Dose Intensity Changes during Cycles of Standard Regimens in Patients with Diffuse Large B-Cell Lymphoma. Cancers. 15(18). 4458–4458. 1 indexed citations
3.
Yamada, Toshiki & Hisashi Tsurumi. (2023). MO12-2 G-CVP therapy using obinutuzumab for follicular lymphoma. Annals of Oncology. 34. S1404–S1404.
4.
5.
Kanemura, Nobuhiro, Nobuhiko Nakamura, Yuhei Shibata, et al.. (2023). The pretreatment Controlling Nutritional Status score is an independent prognostic factor in elderly patients with diffuse large B-cell lymphoma. Leukemia & lymphoma. 65(3). 339–345. 4 indexed citations
6.
Lee, Shin, Tetsuji Morishita, Tetsuya Tsujikawa, et al.. (2023). Prognostic value of metabolic tumor volume of extranodal involvement in diffuse large B cell lymphoma. Annals of Hematology. 102(5). 1141–1148. 2 indexed citations
7.
Hara, Takeshi, et al.. (2021). Natural history of inferior mesenteric arteriovenous malformation that led to ischemic colitis: A case report. World Journal of Clinical Cases. 9(2). 396–402. 1 indexed citations
8.
Yamada, Toshiki, et al.. (2016). Multiple myeloma with Russell bodies and needle-shaped crystalline inclusions. International Journal of Hematology. 103(5). 483–485.
9.
Nakamura, Nobuhiko, Takeshi Hara, Yuhei Shibata, et al.. (2015). Sarcopenia is an independent prognostic factor in male patients with diffuse large B-cell lymphoma. Annals of Hematology. 94(12). 2043–2053. 79 indexed citations
10.
Fukuno, Kenji, Takeshi Hara, Hisashi Tsurumi, et al.. (2014). Expression of indoleamine 2,3-dioxygenase in leukemic cells indicates an unfavorable prognosis in acute myeloid leukemia patients with intermediate-risk cytogenetics. Leukemia & lymphoma. 56(5). 1398–1405. 35 indexed citations
11.
Nagano, Junji, Masahito Shimizu, Takeshi Hara, et al.. (2013). Effects of Indoleamine 2,3-Dioxygenase Deficiency on High-Fat Diet-Induced Hepatic Inflammation. PLoS ONE. 8(9). e73404–e73404. 49 indexed citations
12.
Shimizu, Masahito, Yoichi Yasuda, Hiroyasu Sakai, et al.. (2011). Pitavastatin suppresses diethylnitrosamine-induced liver preneoplasms in male C57BL/KsJ-db/dbobese mice. BMC Cancer. 11(1). 281–281. 43 indexed citations
13.
Shimizu, Masahito, Hiroyasu Sakai, Yohei Shirakami, et al.. (2010). Acyclic Retinoid Inhibits Diethylnitrosamine-Induced Liver Tumorigenesis in Obese and Diabetic C57BLKS/J- +Lepr db /+Lepr db Mice. Cancer Prevention Research. 4(1). 128–136. 49 indexed citations
14.
Yasuda, Yoichi, Masahito Shimizu, Hiroyasu Sakai, et al.. (2009). (−)-Epigallocatechin gallate prevents carbon tetrachloride-induced rat hepatic fibrosis by inhibiting the expression of the PDGFRβ and IGF-1R. Chemico-Biological Interactions. 182(2-3). 159–164. 51 indexed citations
15.
Hara, Takeshi, Hisashi Tsurumi, Naoe Goto, et al.. (2009). Serum soluble Fas level determines clinical outcome of patients with diffuse large B-cell lymphoma treated with CHOP and R-CHOP. Journal of Cancer Research and Clinical Oncology. 135(10). 1421–1428. 12 indexed citations
16.
Shimizu, Masahito, et al.. (2008). Synergistic Growth Inhibition by 9-cis-Retinoic Acid Plus Trastuzumab in Human Hepatocellular Carcinoma Cells. Clinical Cancer Research. 14(9). 2806–2812. 28 indexed citations
17.
Sawada, K, Mitsuyoshi Hirokawa, Naohito Fujishima, et al.. (2007). Long-term outcome of patients with acquired primary idiopathic pure red cell aplasia receiving cyclosporine A. A nationwide cohort study in Japan for the PRCA Collaborative Study Group. Haematologica. 92(8). 1021–1028. 65 indexed citations
18.
Matsuyama, Zenjiro, Yasuyuki Suzuki, Hisashi Tsurumi, et al.. (2004). [Diagnosis of adult type of Niemann-Pick disease (type C) in two brothers by filipin staining of bone marrow smears].. PubMed. 56(12). 1047–53. 2 indexed citations
19.
Hara, Takeshi, et al.. (2001). [Hypereosinophilic syndrome with DIC treated successfully with a combination of high-dose methylprednisolone and cyclosporin A].. PubMed. 42(11). 1145–7. 6 indexed citations
20.
Tsurumi, Hisashi, et al.. (1995). [Acute myelogenous leukemia with diabetes insipidus without desmopression administration by anti-leukemic chemotherapy].. PubMed. 36(12). 1359–64. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dilip K. Deb Breakdown of academic impact, for papers by Patrick D. Walker Breakdown of academic impact, for papers by Salvatore Mancuso Breakdown of academic impact, for papers by Lynell W. Klassen Breakdown of academic impact, for papers by Yasumasa Ikeda Breakdown of academic impact, for papers by Karen W. Makar Breakdown of academic impact, for papers by James P. Luyendyk Breakdown of academic impact, for papers by Huihua Li Breakdown of academic impact, for papers by Roger Feakins Breakdown of academic impact, for papers by Josep M. Piqué
Rankless by CCL
2026